Celgene Aktie
WKN: 881244 / ISIN: US1510201049
17.04.2019 18:10:00
|
Bristol-Myers Squibb Company -- Moody's assigns A2 to Bristol-Myers's exchange notes; under review for downgrade
Rating Action: Moody's assigns A2 to Bristol-Myers's exchange notes; under review for downgrade